Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial.

World journal of clinical cases(2023)

引用 0|浏览15
暂无评分
摘要
There were no significant differences in biochemical or anthropometric parameters, between the two groups evaluated. Nevertheless, there were significant postprocedural differences in the microbiota composition between the placebo group. To date, clinical outcomes related to FMT remain uncertain.
更多
查看译文
关键词
fecal microbiota transplantation,metabolic syndrome,obesity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要